US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Merck Animal Health Expands Voluntary Recall with Four Additional Lots of BANAMINE® / BANAMINE®-S (flunixin meglumine injection) in the U.S., Due to Presence of Particulate Matter

      Summary Company Announcement Date: September 29, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Featured / Makers of Raptiva Remove Psoriasis Drug From Market Due to PML Risks

Makers of Raptiva Remove Psoriasis Drug From Market Due to PML Risks

April 8, 2009 By E. Sizemore 4 Comments

RaptivaRaptiva will no longer be available in the United States By June 8, 2009. Genentech, makers of the psoriasis drug Raptiva (efalizumab) have announced a voluntary withdrawal of the drug from the US market after learning of a rare but serious risk to patients taking the drug.

The risk factor behind this recall is progressive multifocal leukoencephalopathy (PML), a rare but serious, progressive neurologic disease caused by a virus that affects the central nervous system.

Healthcare professionals should not initiate Raptiva treatment for new patients and should immediately contact current patients who have been prescribed Raptiva to discuss other treatment options for psoriasis.

While PML usually only occurs in people whose immune systems have been severely weakened, it often leads to an irreversible decline in neurologic function and eventually death.

Raptiva is a once-weekly injection for adults with moderate to severe plaque psoriasis. See our earlier warning here.

Doctors with questions about Raptiva may contact Genentech Medical Communications at (800) 821-8590. Patients should contact their doctor.

If you have developed progressive multifocal leukoencephalopathy (PML) after taking Raptiva, and have already seen your doctor, you may have legal recourse. Use the form below to find out.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Featured

About E. Sizemore

Comments

  1. Debra Stuart says

    April 16, 2009 at 7:08 pm

    Three years ago I was diagnosed with subacute lupus . I was put on plaquenil. thiladomide nothing seemed to work. I was confined to the house because I was so photosensitive. Breaking out all over chest ,arms ,back, feet. I was so depressed I didn’t want to live anymore. Then the dermatoligist said that he had been reading on this new Drug Raptiva and wanted me to try it. So I did and it cleared my lupus up and gave me my life back. I went back to work had a life again and now the RECALL! How about that I am back at square one.This has took all the hope I had for a life away again. I don’t think there are as many risks with this as some of the other medicine on the market today if people would just read the labels!

    Reply

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Merck Animal Health Expands Voluntary Recall with Four Additional Lots of BANAMINE® / BANAMINE®-S (flunixin meglumine injection) in the U.S., Due to Presence of Particulate Matter

September 28, 2023 By The FDA

Dick Taylor Craft Chocolate Issues Recall for Allergy Allert on Undeclared Peanuts in “Ginger Snap Milk Chocolate”

September 27, 2023 By The FDA

Penzeys Spices Issues Allergy Alert on Undeclared Sesame Seeds in “Brady Street Cheese Sprinkle”

September 27, 2023 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Nutraceutical Recalls Solaray Liposomal Multivitamins Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

September 27, 2023 By The CPSC

Rust-Oleum Recalls Fluorescent Pink Spray Paint Due to Injury Hazard

September 27, 2023 By The CPSC

Secura Recalls Air Fryers Due to Fire and Burn Hazards (Recall Alert)

September 27, 2023 By The CPSC

Polaris Recalls Ranger Recreational Off-Highway Vehicles and Pro XD Utility Vehicles, Gravely ATLAS Utility Vehicles, and Bobcat Utility Vehicles Due to Injury Hazard (Recall Alert)

September 27, 2023 By The CPSC

SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance

September 26, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Polaris Recalls Ranger Recreational Off-Highway Vehicles and Pro XD Utility Vehicles, Gravely ATLAS Utility Vehicles, and Bobcat Utility Vehicles Due to Injury Hazard (Recall Alert)

September 27, 2023 By The CPSC

SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) Due to Potential for Cross Contamination with a Non-Antibacterial ßlactam Drug Substance

September 26, 2023 By The FDA

Eagle Produce LLC Recalls Whole Cantaloupe Because of Possible Health Risk

September 26, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Merck Animal Health Expands Voluntary Recall with Four Additional Lots of BANAMINE® / BANAMINE®-S (flunixin meglumine injection) in the U.S., Due to Presence of Particulate Matter
  • Dick Taylor Craft Chocolate Issues Recall for Allergy Allert on Undeclared Peanuts in “Ginger Snap Milk Chocolate”
  • Penzeys Spices Issues Allergy Alert on Undeclared Sesame Seeds in “Brady Street Cheese Sprinkle”
  • Trek Recalls Allant+ 7 Bicycles Due to Crash Hazard
  • Procter & Gamble Recalls Zevo Fly, Gnat and Fruit Fly Insect Spray Due to Injury and Laceration Hazards
  • Nutraceutical Recalls Solaray Liposomal Multivitamins Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning
  • Rust-Oleum Recalls Fluorescent Pink Spray Paint Due to Injury Hazard
  • Secura Recalls Air Fryers Due to Fire and Burn Hazards (Recall Alert)
  • Polaris Recalls Ranger Recreational Off-Highway Vehicles and Pro XD Utility Vehicles, Gravely ATLAS Utility Vehicles, and Bobcat Utility Vehicles Due to Injury Hazard (Recall Alert)
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in